Navigation Links
Effect of adenotonsillectomy in children with sleep-disordered breathing
Date:12/19/2011

Alexandria, VA -- Children may have a better quality of life (QOL) and diminished cardiovascular disease risk from the decreased endothelin 1 (ET-1) levels after adenotonsillectomy, according to new research published in the December 2011 issue of Otolaryngology Head and Neck Surgery.

SDB is an increasingly common indication for tonsillectomy and adenoidectomy due to obstructive sleep apnea syndrome (OSAS). Cardiovascular (CV) disease frequently has been reported in patients with moderate to severe OSAS, related abnormalities include: systematic hypertension, pulmonary hypertension with corpulmonale, left ventricular (LV) hypertrophy or dysfunction, cardiac arrhythmias, atherosclerosis, and coronary artery disease.

The study sample included an obstructive sleep apnea survey and a detailed personal and family history. All subjects underwent a complete otolaryngologic examination, otoscopy, and anterior rhinoscopy. Thirty-seven children with a diagnosis of upper airway obstruction caused by adenotonsillar hypertrophy (ATH) were included in the study. Twenty female and 17 male patients, between 3 and 13 years old participated in the study.

Surgical procedures included: 20 tonsillectomies and adenoidectomies (54%), 15 adenoidectomies only (40.6%), and 2 tonsillectomies only (5.4%). Study results show when comparing moderate and severe cases to mild cases according to Brouilette scores, ET-1 levels were significantly higher in moderate and severe cases (P <.01). There was a significant correlation between ET-1 and the OSA-18 survey scale (r =0.442; P =.001).

The objective of the study was to evaluate the influence of adenotonsillectomy on the plasma concentration of ET-1 levels and C-reactive protein (CRP) in children with sleep-disordered breathing (SDB). The primary goal of this research study was to investigate the effect of ATH and adenotonsillectomy on the possible pathogenic mechanisms (endothelial dysfunction and inflammation) that lead to cardiovascular complications.

Based on the study findings, the authors indicate: "that children with SDB who undergo adenotonsillectomy may have a better QOL, and the positive influence of adenotonsillectomy on CV function might be mediated by the decrease in ET-1 levels." The study's authors acknowledge that more research is needed, noting: "Further studies with longer follow-up and a larger population sample are warranted to demonstrate the association between SDB due to ATH and ET-1 levels and to confirm the influence of adenotonsillectomy on ET-1 and CRP levels to prevent cardiovascular disease in children."


'/>"/>
Contact: Mary Stewart
mstewart@entnet.org
703-535-3762
American Academy of Otolaryngology - Head and Neck Surgery
Source:Eurekalert

Related medicine news :

1. Heart drug may be effective for managing certain cancers: Queens University study
2. Side Effects Cause Many Older Women to Drop Breast Cancer Drugs
3. Behavior of people faced with health-care choices is not influenced by framing effect, study finds
4. Study finds side effects, complications, mastectomy more likely after partial breast irradiation
5. Reusing pacemakers from deceased patients is safe and effective, study finds
6. If a fat tax is coming, heres how to make it efficient, effective: ISU economists
7. Drug May Dampen Dangerous Side Effect of Stem Cell Transplants
8. Researchers validate preclinical effectiveness of TB drug target
9. Tenofovir gel dropped from HIV prevention trial in women because it was not effective
10. Similar effects of beer and wine on the risk of cardiovascular disease
11. Tamoxifen causes significant side effects in male breast cancer patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... ... February 17, 2017 , ... While EHR data has revolutionized ... an innovative workstation designed to reduce nursing fatigue while enhancing productivity. Based on ... offers a lightweight, highly mobile, multi-functional alternative to the limitations of handheld computing. ...
(Date:2/17/2017)... FL (PRWEB) , ... February 17, 2017 , ... ... software tools that allow for the electronic prescribing of controlled and non-controlled substances ... , Ninety percent of pharmacies in the United States now accept electronic prescriptions, ...
(Date:2/17/2017)... (PRWEB) , ... February 17, ... ... Device Approval and Reimbursement , **An FDAnews Webinar**, Feb. 22, 2017 — ... are the critical reimbursement questions manufacturers should be asking before selecting an ...
(Date:2/17/2017)... ... February 17, 2017 , ... ... a Warning Letter, **An FDAnews Webinar**, Feb. 23, 2017 — 1:30 p.m. – ... between corrective action (CA) and preventive action (PA)? , The methods share techniques ...
(Date:2/17/2017)... Springs, Texas (PRWEB) , ... February 17, 2017 ... ... Signature 8.0 at the HIMSS17 Conference & Exhibition in Orlando, Fla., February 19-23. ... latest version of the most widely used electronic patient signatures solution in ...
Breaking Medicine News(10 mins):
(Date:2/18/2017)... Research and Markets has announced the addition of the "Contraceptives - ... ... the US, Canada , Japan , ... Latin America , and Rest of World. Annual estimates and forecasts ... analysis is provided for these markets. Market data and analytics are derived ...
(Date:2/17/2017)... 2017  Ethicon, Inc. today announced a definitive ... held medical device company that manufactures and markets ... novel minimally invasive device for the surgical treatment ... enable Ethicon to offer patients a safe and ... surgical procedure. 1 This LINX ...
(Date:2/17/2017)... Theravance Biopharma, Inc. (NASDAQ: ... announced the presentation of positive clinical data for ... kinase (JAK) inhibitor designed to be intestinally restricted, ... European Crohn,s and Colitis Organization (ECCO). In a ... its completed Phase 1 study of single-ascending and ...
Breaking Medicine Technology: